CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760

por Yuan, Jianjun, Liu, Yan, Zhang, Quan, Ren, Zhishuai, Li, Guang, Tian, Rong
Publicado 2021

Expression and clinical significance of UBE2V1 in cervical cancer

por Ren, Zhishuai, Liu, Zhendong, Ma, Shenqian, Yue, Junming, Yang, Jinming, Wang, Ruiya, Gao, Yanzheng, Guo, Yuqi
Publicado 2021

Correlation between C7–T1 Intervertebral Foramen Area and Sagittal Parameters in Patients with Cervical Spondylotic Myelopathy

por Zhang, Lilong, Cui, Zijian, Yuan, Chen, Zhang, Xueli, Ren, Zhishuai, Wang, Wei, Xia, Ping, Zhu, Rusen
Publicado 2022

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma

por Wang, Jialin, Liu, Binfeng, Yao, Jiawei, Liu, Zhendong, Wang, Hongbo, Zhang, Bo, Lian, Xiaoyu, Ren, Zhishuai, Liu, Liyun, Gao, Yanzheng
Publicado 2021

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma

por Cheng, Xingbo, Ren, Zhishuai, Liu, Zhendong, Sun, Xiang, Qian, Rongjun, Cao, Chen, Liu, Binfeng, Wang, Jialin, Wang, Hongbo, Guo, Yuqi, Gao, Yanzheng
Publicado 2022

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma

por Liu, Zhendong, Lian, Xiaoyu, Zhang, Xiuru, Zhu, Yongjie, Zhang, Wang, Wang, Jialin, Wang, Hongbo, Liu, Binfeng, Ren, Zhishuai, Zhang, Mengjun, Liu, Mingyang, Gao, Yanzheng
Publicado 2021

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma

por Liu, Zhendong, Ren, Zhishuai, Zhang, Cheng, Qian, Rongjun, Wang, Hongbo, Wang, Jialin, Zhang, Wang, Liu, Binfeng, Lian, Xiaoyu, Wang, Yanbiao, Guo, Yuqi, Gao, Yanzheng
Publicado 2021

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients

por Wang, Jialin, Liu, Zhendong, Zhang, Cheng, Wang, Hongbo, Li, Ang, Liu, Binfeng, Lian, Xiaoyu, Ren, Zhishuai, Zhang, Wang, Wang, Yanbiao, Zhang, Bo, Pang, Bo, Gao, Yanzheng
Publicado 2021

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells

por Liu, Zhendong, Wang, Hongbo, Jia, Yulong, Wang, Jialin, Wang, Yanbiao, Bian, Lu, Liu, Binfeng, Lian, Xiaoyu, Zhang, Bo, Ren, Zhishuai, Zhang, Wang, Dai, Weiwei, Gao, Yanzheng
Publicado 2021

ITGB3BP is a potential biomarker associated with poor prognosis of glioma

por Liu, Zhendong, Liu, Binfeng, Bian, Lu, Wang, Hongbo, Jia, Yulong, Wang, Yubo, Zhang, Wang, Wang, Yanbiao, Han, Zhibin, Cheng, Xingbo, Lian, Xiaoyu, Ren, Zhishuai, Gao, Yanzheng
Publicado 2021

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes

por Yu, Zhenghong, Liu, Zhendong, Lian, Xiaoyu, Cheng, Xingbo, Liu, Binfeng, Zhang, Bo, Wang, Hongbo, Wang, Jialin, Li, Ang, Ren, Zhishuai, Pang, Bo, Qian, Rongjun, Gao, Yanzheng
Publicado 2022

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma

por Zhang, Wang, Liu, Zhendong, Liu, Binchao, Jiang, Miaomiao, Yan, Shi, Han, Xian, Shen, Hong, Na, Meng, Wang, Yanbiao, Ren, Zhishuai, Liu, Binfeng, Jiang, Zhenfeng, Gao, Yanzheng, Lin, Zhiguo
Publicado 2021

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients

por Liu, Zhendong, Zhang, Wang, Cheng, Xingbo, Wang, Hongbo, Bian, Lu, Wang, Jialin, Han, Zhibin, Wang, Yanbiao, Lian, Xiaoyu, Liu, Binfeng, Ren, Zhishuai, Zhang, Bo, Jiang, Zhenfeng, Lin, Zhiguo, Gao, Yanzheng
Publicado 2021